EP.13.28 Assessment of Clinical Characteristics and Outcomes of Brazilian ES-SCLC Patients on First Line Durvalumab + Chemotherapy
Back to course
Asset Subtitle
Mauro Zukin
Meta Tag
Speaker Mauro Zukin
Topic Small Cell Lung Cancer and Neuroendocrine Tumors
Powered By